Congenital erythropoietic porphyria (CEP) is an autosomal recessive disorder with deficiency of uroporphyrinogen III cosynthase. Accumulation of uroporphyrin I is responsible for the oxygen-dependent phototoxic dermatological, skeletal, visceral, and ocular damage. [1, 2] The dermatological changes include skin ulceration and extensive mutilation in the sun exposed area.
Ocular complications of CEP include nodular scleritis, necrotizing scleritis with inflammation or scleromalacia perforans. Necrotizing scleritis and scleromalacia perforans are among the most commonly reported ocular complications. [3, 4] In our case, the patient had visual acuity of 6/12 in both eyes with scleritis, scleral thinning, and scleral calcific plaques evident on slit lamp examination This case highlights the importance of awareness about the ocular complications in CEP that every general practitioner must be acquainted with and the fact that such a presentation should not be confused with an infective etiology.
Conclusion
CEP is a rare disorder but can be associated with serious ocular complications, such as scleral melting and blindness. The treating physician must be aware of the ocular complications of this entity to ensure timely referral to an ophthalmologist for accurate diagnosis and prompt treatment.
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